vs

亚玛芬体育(AS)与查尔斯河实验室(CRL)财务数据对比。点击上方公司名可切换其他公司

亚玛芬体育的季度营收约是查尔斯河实验室的1.1倍($1.1B vs $995.8M),亚玛芬体育净利率更高(1.8% vs -1.5%,领先3.3%)

亚玛芬体育是芬兰跨国运动装备企业,总部位于赫尔辛基,成立于1950年。早年为涉足烟草贸易、航运、出版等领域的多元化工业集团,后逐步转型专注于体育用品的生产与营销,现有员工超9700人,2018年起成为中国安踏体育旗下子公司。

查尔斯河实验室国际是总部位于美国马萨诸塞州威尔明顿的医药及生物技术领域合同研究组织(CRO),成立于1947年,可为新药、疫苗及医疗器械的研发提供临床前和临床阶段的专业实验室服务。

AS vs CRL — 直观对比

营收规模更大
AS
AS
是对方的1.1倍
AS
$1.1B
$995.8M
CRL
净利率更高
AS
AS
高出3.3%
AS
1.8%
-1.5%
CRL

损益表 — Q1 FY2024 vs Q1 FY2026

指标
AS
AS
CRL
CRL
营收
$1.1B
$995.8M
净利润
$19.0M
$-14.8M
毛利率
52.8%
营业利润率
12.4%
12.0%
净利率
1.8%
-1.5%
营收同比
1.2%
净利润同比
-157.2%
每股收益(稀释后)
$0.05
$-0.30

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
AS
AS
CRL
CRL
Q1 26
$995.8M
Q4 25
$994.2M
Q3 25
$1.0B
Q2 25
$1.0B
Q1 25
$984.2M
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.0B
净利润
AS
AS
CRL
CRL
Q1 26
$-14.8M
Q4 25
$-276.6M
Q3 25
$54.4M
Q2 25
$52.3M
Q1 25
$25.5M
Q4 24
$-214.5M
Q3 24
$69.7M
Q2 24
$94.1M
毛利率
AS
AS
CRL
CRL
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
34.6%
Q2 24
34.5%
营业利润率
AS
AS
CRL
CRL
Q1 26
12.0%
Q4 25
-28.5%
Q3 25
13.3%
Q2 25
9.7%
Q1 25
7.6%
Q4 24
-16.7%
Q3 24
11.6%
Q2 24
14.8%
净利率
AS
AS
CRL
CRL
Q1 26
-1.5%
Q4 25
-27.8%
Q3 25
5.4%
Q2 25
5.1%
Q1 25
2.6%
Q4 24
-21.4%
Q3 24
6.9%
Q2 24
9.2%
每股收益(稀释后)
AS
AS
CRL
CRL
Q1 26
$-0.30
Q4 25
$-5.57
Q3 25
$1.10
Q2 25
$1.06
Q1 25
$0.50
Q4 24
$-4.17
Q3 24
$1.33
Q2 24
$1.74

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
AS
AS
CRL
CRL
现金及短期投资手头流动性
$191.8M
总债务越低越好
股东权益账面价值
$2.9B
总资产
$7.7B
负债/权益比越低杠杆越低

8季度趋势,按日历期对齐

现金及短期投资
AS
AS
CRL
CRL
Q1 26
$191.8M
Q4 25
$213.8M
Q3 25
$207.1M
Q2 25
$182.8M
Q1 25
$229.4M
Q4 24
$194.6M
Q3 24
$210.2M
Q2 24
$179.2M
总债务
AS
AS
CRL
CRL
Q1 26
Q4 25
$2.1B
Q3 25
$2.2B
Q2 25
$2.3B
Q1 25
$2.5B
Q4 24
$2.2B
Q3 24
$2.3B
Q2 24
$2.4B
股东权益
AS
AS
CRL
CRL
Q1 26
$2.9B
Q4 25
$3.2B
Q3 25
$3.4B
Q2 25
$3.4B
Q1 25
$3.2B
Q4 24
$3.5B
Q3 24
$3.8B
Q2 24
$3.7B
总资产
AS
AS
CRL
CRL
Q1 26
$7.7B
Q4 25
$7.1B
Q3 25
$7.5B
Q2 25
$7.6B
Q1 25
$7.6B
Q4 24
$7.5B
Q3 24
$8.0B
Q2 24
$7.9B
负债/权益比
AS
AS
CRL
CRL
Q1 26
Q4 25
0.68×
Q3 25
0.64×
Q2 25
0.70×
Q1 25
0.79×
Q4 24
0.65×
Q3 24
0.62×
Q2 24
0.65×

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
AS
AS
CRL
CRL
经营现金流最新季度
$114.3M
$41.1M
自由现金流经营现金流 - 资本支出
$92.2M
自由现金流率自由现金流/营收
8.8%
资本支出强度资本支出/营收
2.1%
5.6%
现金转化率经营现金流/净利润
6.02×
过去12个月自由现金流最近4个季度

8季度趋势,按日历期对齐

经营现金流
AS
AS
CRL
CRL
Q1 26
$41.1M
Q4 25
$147.5M
Q3 25
$213.8M
Q2 25
$204.6M
Q1 25
$171.7M
Q4 24
$159.4M
Q3 24
$251.8M
Q2 24
$193.5M
自由现金流
AS
AS
CRL
CRL
Q1 26
Q4 25
$58.6M
Q3 25
$178.2M
Q2 25
$169.3M
Q1 25
$112.4M
Q4 24
$83.7M
Q3 24
$213.1M
Q2 24
$154.0M
自由现金流率
AS
AS
CRL
CRL
Q1 26
Q4 25
5.9%
Q3 25
17.7%
Q2 25
16.4%
Q1 25
11.4%
Q4 24
8.4%
Q3 24
21.1%
Q2 24
15.0%
资本支出强度
AS
AS
CRL
CRL
Q1 26
5.6%
Q4 25
8.9%
Q3 25
3.5%
Q2 25
3.4%
Q1 25
6.0%
Q4 24
7.5%
Q3 24
3.8%
Q2 24
3.8%
现金转化率
AS
AS
CRL
CRL
Q1 26
Q4 25
Q3 25
3.93×
Q2 25
3.91×
Q1 25
6.74×
Q4 24
Q3 24
3.61×
Q2 24
2.06×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

AS
AS

Americas2$409.6M39%
EMEA1$356.9M34%
Greater China3$205.6M20%
Asia Pacific4$78.2M7%

CRL
CRL

Service revenue$798.2M80%
Product revenue$197.7M20%

相关对比